Living with depression that does not respond to standard treatments can feel confusing and discouraging. You may have tried medications, therapy, or lifestyle changes and still feel stuck in the same heavy place. Over time, you may start to feel like your brain is working against you, making it harder to feel motivated, hopeful, or connected, even when you are doing everything you are supposed to.
Fortunately, newer treatment options can make a meaningful difference in treating depressive symptoms. SPRAVATO® is an esketamine treatment tied to advances in understanding how depression affects the brain. If you are tired of feeling frustrated by limited results from past treatments, learning how SPRAVATO® works may help you feel more informed and encouraged about your options. Contact Genesis Behavioral Health Services today to schedule a visit and learn more.
SPRAVATO® is a treatment for severe depression. Unlike most antidepressants that focus on serotonin or norepinephrine, SPRAVATO® works by targeting the glutamate system in the brain. Glutamate is a chemical messenger involved in learning, memory, and mood regulation, and it plays a key role in how brain cells communicate with each other.
Research shows that depression can disrupt these communication pathways, especially in areas of the brain involved in mood and stress response. SPRAVATO® increases glutamate activity in a controlled way, helping to restore connections between brain cells. This process is thought to support healthier brain signaling and may lead to improvements in mood, energy, and overall functioning.
SPRAVATO® is administered under medical supervision in a certified health care setting. While you will self-administer the nasal spray, a trained medical team will be present to monitor you during each session. This supervised approach helps ensure safety and allows your care team to support you through the experience. SPRAVATO®’s unique effect on brain pathways differs from a slow chemical buildup over weeks, making it important to track your response to the medication.
The development of SPRAVATO® began with decades of research into ketamine and its effects on mood. Researchers noticed that low doses of ketamine could reduce depressive symptoms rapidly, even in people who had not responded to other treatments. This discovery was a significant shift from traditional antidepressants, which often take weeks to show results.
Due to this research, esketamine was isolated as a component that could be delivered safely through a nasal spray. Clinical trials demonstrated that SPRAVATO®, when used alongside an oral antidepressant, could reduce symptoms of treatment-resistant depression for many patients. These studies also helped lead to the creation of guidelines for dosing, monitoring, and safety.
In 2019, the FDA approved SPRAVATO® for adults with treatment-resistant depression. Later approvals expanded its use, alongside an oral antidepressant, for adults with major depressive disorder and acute suicidal thoughts or behaviors. Understanding the story behind how this treatment operates helps explain why SPRAVATO® is considered a breakthrough option for those living with depression.
When depression feels unrelenting, having clear information can restore a sense of control. Learning the science and history behind this treatment can help you feel more confident asking questions and exploring whether it fits your needs. SPRAVATO® represents a different approach, built on years of research and careful clinical study.
If you are curious about how SPRAVATO® works and whether it may be appropriate for you, our office is here to help. A conversation with our team at Genesis Behavioral Health Services can give you personalized guidance and next steps. Contact us today to begin your journey toward improved mental health.